A high throughput assay of the hepatitis C virus nonstructural protein 3 serine proteinase.

A simple assay was developed based on intramolecular fluorescence resonance energy transfer for detection of the activity of hepatitis C virus (HCV) serine proteinase. Two quenched-fluorogenic substrates, (7-methoxycoumarin-4-yl)acetyl (Mca) Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-(2,4-dinitrophenyl, Dnp) Lys (Mca-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Ser-Lys[Dnp], QF-1) and Mca-Asp-Asp-Ile-Val-Pro-Cys-Ser-Met-Lys(Dnp)-Arg-Arg (QF-2), which derived from the NS5A/5B junction of the HCV polyprotein, were designed. Kinetic studies revealed that QF-1 and QF-2 had high affinity for a recombinant enzyme which is a fusion protein of maltose binding protein and almost entire nonstructural protein (MBP-NS3), with Km values comparable to that of longer substrate based on the same cleavage site. QF-1 and QF-2 were cleaved by MBP-NS3 efficiently with kcat values of 7.5 and 4.2 min(-1), respectively. QF-2 was also found to be a good substrate of deltaNS3 which contained serine proteinase part of NS3 with kcat value of 4.3 min(-1). The cleavage reaction is detected continuously by the elevation of the fluorescence due to release from quenching. The fluorescence of the substrates increases in proportion to progress of the cleavage reaction under the standard conditions. This method was applied for screening of HCV serine protease inhibitors using a fluorescence multiwell plate reader. A group of natural occurring products, flavonoids, was subjected to be screened. Two flavonoids out of 25 were found to inhibit the enzyme moderately at a concentration of 100 microM. The data agreed with those obtained by high-performance liquid chromatography (HPLC). This method is suited to sensitive quantitation of the enzyme reaction as well as the high throughput analysis of the inhibitors.

[1]  C. Rice,et al.  Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites , 1993, Journal of virology.

[2]  E. Sausville,et al.  Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. , 1996, Cancer research.

[3]  R. Bartenschlager,et al.  Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions , 1993, Journal of virology.

[4]  K. Shimotohno,et al.  Non‐peptide inhibitors of HCV serine proteinase , 1998, FEBS letters.

[5]  K. Shimotohno,et al.  Substrate requirements of hepatitis C virus serine proteinase for intermolecular polypeptide cleavage in Escherichia coli , 1994, Journal of virology.

[6]  A. Urbani,et al.  Activity of purified hepatitis C virus protease NS3 on peptide substrates , 1996, Journal of virology.

[7]  M. Houghton,et al.  The hepatitis C virus encodes a serine protease involved in processing of the putative nonstructural proteins from the viral polyprotein precursor. , 1993, Biochemical and biophysical research communications.

[8]  R. Francesco,et al.  Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins , 1994, Journal of virology.

[9]  M. Houghton,et al.  Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease , 1991, Hepatology.

[10]  K. Shimotohno,et al.  Expression of highly active recombinant NS3 protease domain of hepatitis C virus in E. coli , 1997, FEBS letters.

[11]  P. Barr,et al.  Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Urbani,et al.  A continuous assay of hepatitis C virus protease based on resonance energy transfer depsipeptide substrates. , 1996, Analytical biochemistry.

[13]  R. De Francesco,et al.  NS3 is a serine protease required for processing of hepatitis C virus polyprotein , 1993, Journal of virology.

[14]  J. Crouzet,et al.  Glycosylated flavones as selective inhibitors of topoisomerase IV , 1997, Antimicrobial agents and chemotherapy.

[15]  C. Rice,et al.  Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics , 1994, Journal of virology.

[16]  M. Murcko,et al.  Crystal Structure of the Hepatitis C Virus NS3 Protease Domain Complexed with a Synthetic NS4A Cofactor Peptide , 1996, Cell.

[17]  T. Sugimura,et al.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Fields,et al.  Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). , 1994, The Journal of biological chemistry.

[19]  N. Kato,et al.  Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Shimotohno,et al.  Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing , 1995, Journal of virology.

[21]  S. Kaufmann,et al.  Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. , 1996, Cancer research.

[22]  N. Kato,et al.  Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus , 1993, Journal of virology.

[23]  K. Shimotohno,et al.  An enzyme-linked immunosorbent assay for detecting proteolytic activity of hepatitis C virus proteinase. , 1997, Analytical biochemistry.

[24]  K. Shimotohno,et al.  Bacterial expression and analysis of cleavage activity of HCV serine proteinase using recombinant and synthetic substrate. , 1995, Biochemical and biophysical research communications.

[25]  H. Okayama,et al.  Production of nonstructural proteins of hepatitis C virus requires a putative viral protease encoded by NS3. , 1994, Virology.

[26]  J. Coligan,et al.  Casein kinase II is a selective target of HIV-1 transcriptional inhibitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  S. Kunitada,et al.  Identification of the domain required for trans-cleavage activity of hepatitis C viral serine proteinase. , 1994 .

[28]  K. Shimotohno,et al.  Processing of hepatitis C viral polyprotein in Escherichia coli. , 1994, Gene.

[29]  H. Okayama,et al.  Structure and organization of the hepatitis C virus genome isolated from human carriers , 1991, Journal of virology.